A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients.
Elham DidariNegar SarhangiMahdi AfshariHamid Reza Aghaei MeybodiMandana HasanzadPublished in: Journal of diabetes and metabolic disorders (2021)
variant.